LifeVantage
February 5, 2025
SALT LAKE CITY, February 5, 2025 --
LifeVantage reported record fiscal second-quarter 2025 revenue of 67.8 million dollars, up 31.3 percent from a year earlier, as Americas revenue rose 46.3 percent, including 48.8 percent growth in the United States. Asia/Pacific and Europe revenue fell 15.5 percent. Net income was 2.6 million dollars, or 0.19 dollars per diluted share, versus a loss of 0.05 dollars a year earlier, and adjusted EBITDA more than doubled to 6.5 million dollars.
President and Chief Executive Steve Fife credited strong demand for the MindBody GLP-1 System launched in the U.S. in October, saying enrollments reached their highest level in five years and Americas active accounts rose 25 percent sequentially.
The company raised fiscal 2025 guidance to revenue of 235 million to 245 million dollars from 200 million to 210 million dollars, adjusted EBITDA of 21 million to 24 million dollars and adjusted EPS of 0.72 to 0.88 dollars. It ended the quarter with 21.6 million dollars in cash and no debt and declared a 0.04 dollar quarterly dividend.